Modulating gut microbiota as an anti-diabetic mechanism of berberine.
about
Effect of Rhizoma coptidis (Huang Lian) on Treating Diabetes MellitusIntestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspectiveMetformin and metabolic diseases: a focus on hepatic aspectsHerbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth.A review of the effects of Berberis vulgaris and its major component, berberine, in metabolic syndromeStructural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed ratsO-hexadecyl-dextran entrapped berberine nanoparticles abrogate high glucose stress induced apoptosis in primary rat hepatocytes.Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus.Application of berberine on treating type 2 diabetes mellitus.Berberine blocks the relapse of Clostridium difficile infection in C57BL/6 mice after standard vancomycin treatment.Dose-response effect of berberine on bile acid profile and gut microbiota in mice.Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironmentOptimizing HgA1C and glucose monitoring frequency in patients with Type 2 diabetesBerberine protects human renal proximal tubular cells from hypoxia/reoxygenation injury via inhibiting endoplasmic reticulum and mitochondrial stress pathways.Herbal therapies for type 2 diabetes mellitus: chemistry, biology, and potential application of selected plants and compoundsUnderstanding the Effectiveness of Natural Compound Mixtures in Cancer through Their Molecular Mode of Action.Factors Influencing the Gut Microbiota, Inflammation, and Type 2 Diabetes.Alkaloids isolated from natural herbs as the anticancer agents.Amelioration of Intestinal Barrier Dysfunction by Berberine in the Treatment of Nonalcoholic Fatty Liver Disease in Rats.Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway.
P2860
Q26778280-2812D755-2A7E-4E6D-B577-77CC0431A273Q26863476-56EF07A8-5564-4B75-BAD7-C7793ADADC60Q28082736-0CF4C395-0A8A-414E-A39D-33AEEEB060C6Q33648535-D1227827-A867-4DEC-B29E-35550136FE9DQ33819610-3F6C9761-901C-4930-BE91-056EC0E5607CQ34374252-BCE8F97F-A5B8-45D7-8F40-D42180C7FDA3Q35106703-0FDC853F-4D52-402E-9EEC-D857E9287118Q35145862-2B64A9AE-982B-4F4F-9326-51CE9F7511A4Q35226998-5EAD5631-FC1B-4B90-A804-99D4484A4E4DQ35590543-8525B0D1-F177-4051-97B3-9E79B5A43F52Q36166974-FFE88835-CFC7-4905-BE91-04EBFFF0183BQ36544753-F1CE4913-4C57-4614-B549-90FB727A7C43Q36577613-C2B98250-C121-47F9-AB8B-41BCBB34579AQ36690275-B2C97AD3-F534-4BE7-A589-F92D93FC831EQ36801780-0A9DD9F9-82DD-4F9C-8B30-65406091AD1AQ37729331-AFEC42A8-9CE1-4544-BB6C-F4F5056946B9Q39374045-75821E5B-FB31-44B6-BFC3-050CDB5AE4A8Q42324855-E6B34238-B31A-4F12-AA10-4FF2EDE939F4Q47115176-FA9A5EC9-5628-456F-BD23-B1E7B0658340Q55108878-2F377085-176E-419C-9437-760E748E9357
P2860
Modulating gut microbiota as an anti-diabetic mechanism of berberine.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Modulating gut microbiota as an anti-diabetic mechanism of berberine.
@ast
Modulating gut microbiota as an anti-diabetic mechanism of berberine.
@en
type
label
Modulating gut microbiota as an anti-diabetic mechanism of berberine.
@ast
Modulating gut microbiota as an anti-diabetic mechanism of berberine.
@en
prefLabel
Modulating gut microbiota as an anti-diabetic mechanism of berberine.
@ast
Modulating gut microbiota as an anti-diabetic mechanism of berberine.
@en
P2093
P2860
P921
P356
P1476
Modulating gut microbiota as an anti-diabetic mechanism of berberine
@en
P2093
Huiling Lin
Junling Han
Weiping Huang
P2860
P304
P356
10.12659/MSM.881842
P577
2011-07-01T00:00:00Z